Compare HQY & DLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HQY | DLB |
|---|---|---|
| Founded | 2002 | 1965 |
| Country | United States | United States |
| Employees | N/A | 2051 |
| Industry | Business Services | Multi-Sector Companies |
| Sector | Consumer Discretionary | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.9B | 5.8B |
| IPO Year | 2014 | 2004 |
| Metric | HQY | DLB |
|---|---|---|
| Price | $77.76 | $60.55 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 4 |
| Target Price | ★ $115.93 | $90.75 |
| AVG Volume (30 Days) | ★ 814.9K | 640.4K |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.29% |
| EPS Growth | ★ 70.31 | N/A |
| EPS | ★ 1.88 | 0.55 |
| Revenue | ★ $229,525,000.00 | N/A |
| Revenue This Year | $10.44 | $6.22 |
| Revenue Next Year | $7.47 | $3.84 |
| P/E Ratio | ★ $40.83 | $114.47 |
| Revenue Growth | ★ 28.68 | N/A |
| 52 Week Low | $72.76 | $60.14 |
| 52 Week High | $116.65 | $83.25 |
| Indicator | HQY | DLB |
|---|---|---|
| Relative Strength Index (RSI) | 45.34 | 33.55 |
| Support Level | $73.82 | $60.14 |
| Resistance Level | $79.75 | $67.93 |
| Average True Range (ATR) | 2.91 | 1.58 |
| MACD | 0.34 | -0.42 |
| Stochastic Oscillator | 28.95 | 1.93 |
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
Dolby Laboratories Inc. develops technologies that enhance audio and video capture, transmission, and playback, enabling high-quality experiences across movies, TV, music, sports, and more. The company designs and manufactures audio, imaging, accessibility, and related hardware and software mainly for cinema, including digital cinema servers and media encryption and packaging tools. It generates the majority of its revenue by licensing its technology, brand, and patents to device manufacturers and by selling cinema hardware and services. It operates as a single reportable segment, with revenue derived mainly from licensing and, to a lesser extent, from premium cinema technologies, across the United States and international markets.